Food: The main course to wellness and illness in patients with irritable bowel syndrome

American Journal of Gastroenterology

Volumn 111, Issue 3, 2016, Pages 366-371

  Chey, William D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; INULIN; SHORT CHAIN FATTY ACID; CARBOHYDRATE DIET;

COLON FLORA; CONTROLLED CLINICAL TRIAL (TOPIC); DIET RESTRICTION; DIET SUPPLEMENTATION; ENDOCRINE FUNCTION; FOOD INTAKE; FUNCTIONAL FOOD; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LONG TERM CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; WATER CONTENT; WELLBEING; ADVERSE EFFECTS; CARBOHYDRATE DIET; DIET THERAPY; FEEDING BEHAVIOR; FOOD ANALYSIS; NUTRITION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

DIETARY CARBOHYDRATES; FOOD ANALYSIS; FOOD HABITS; HUMANS; IRRITABLE BOWEL SYNDROME; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; QUALITY OF LIFE;

EID: 84957825148     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.12     Document Type: Review

References (37)

1. Longstreth G, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
2. Chey WD, Eswaran S, Kurlander J. Management of irritable bowel syndrome. JAMA 2015; 313: 949-58.
3. Ford AC, Moayyedi P, Lacy BE, et al. ACG monograph on the management of IBS and chronic constipation. Am J Gastroenterol 2014; 109: S2-S26.
4. Bohn L, Storsrud S, Tornblom H, et al. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 2013; 108: 634-41.
5. Nojkov B, Eswaran S, Chey WD. Dietary restrictions predict worse diseasespecific quality of life in patients with irritable bowel syndrome. Gastroenterology 2014; 146: S199.
6. Farre R, Tack J. Food and symptom generation in functional gastrointestinal disorders: physiological aspects. Am J Gastroenterol 2013; 108: 698-706
7. Corley DA, Schuppan D. Food, the immune system, and the gastrointestinal tract. Gastroenterol 2015; 148: 1083-6.
8. Spencer M, Chey WD, Eswaran S. Dietary renaissance in IBS: has food replaced medications as a primary treatment strategy? Curr Treat Options Gastroenterol 2014; 12: 424-40.
9. Gibson PR, Varney J, Malakar S, et al. Food components and irritable bowel syndrome. Gastroenterology 2015; 148: 1158-74.
10. Tilg H, Moschen AR. Food, the immune system, and the gastrointestinal tract. Gastroenterology 2015; 148: 1107-19.
11. Rajilic-Stojanovic M, Jonkers DM, Salonen A, et al. Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol 2015; 110: 278-87.
12. Shepherd SJ, Lomer MCE, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol 2013; 108: 707-17.
13. Bennet SM, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver 2015; 9: 318-31.
14. Simren M, Giovanni B, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013; 62: 159-76.
15. Ringel-Kulka T, Choi CH, Temas D, et al. Altered colonic bacterial fermentation as a potential pathophysiological factor in irritable bowel syndrome. Am J Gastroenterol 2015; 110: 1339-46.
16. Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010; 25: 1366-73.
17. Murray K, Wilkinson-Smith V, Hoad C, et al. Differential effects of FODMAPs (Fermentable Oligo-, Di-, Mono-Saccharides and Polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol 2014; 109: 110-9.
18. Major GA, Pritchard SE, Murray K, et al. A double-blind crossover study using magnetic resonance imaging shows that fructose and inulin mediate symptoms in IBS patients through different mechanisms: early increase in small bowel water versus late increase in colonic gas. Gastroenterol 2015; 148: S55-6.
19. Staudacher HM, Lomer MCE, Anderson JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012; 142: 1510-8.
20. Halmos EP, Christophersen CT, Bird AR, et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015; 64: 93-100.
21. Chumpitazi BP, Cope JL, Hollister EB, et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther 2015; 42: 418-27.
22. Halmos EP, Power VA, Shepherd SJ, et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterol 2014; 146: 67-75.
23. Böhn L, Störsrud S, Liljebo T, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterol 2015; 149: 1399-407.
24. Piacentino D, Rossi S, Alvino V, et al. Low-FODMAP diet in irritable bowel syndrome patients offers more benefit than a low-FODMAP gluten-free diet in the medium-and long-term. results from a double-blind randomized controlled clinical study and follow-up. Gastroenterology 2015; Vol. 148: S119.
25. Whingham L, Joyce T, Harper G, et al. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. J Hum Nutr Diet 2015; 28: 687-96.
26. NICE guidelines for IBS: Available at https://www.nice.org.uk/guidance/cg61/chapter/1-Recommendations. Accessed February 2015.
27. McKenzie YA, Alder A, Anderson W, et al. Gastroenterology Specialist Group of the British Dietetic Association. British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults. J Hum Nutr Diet 2012 Jun; 25: 260-74.
28. Azpiroz F, Hernandez C, Guyonnet D, et al. Effect of a low-flatulogenic diet in patients with flatulence and functional digestive symptoms. Neurogastroenterol Motil 2014; 26: 779-85.
29. Lacy BE. The science, evidence, and practice of dietary interventions in irritable bowel syndrome. Clin Gastroenterol Hepatol 2015; 13: 1899-906.
30. Fritscher-Ravens A, Schuppan D, Ellrichmann M, et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with IBS. Gastroenterol 2014; 147: 1012-20.
31. Ross S. Functional foods: the FDA perspective. Am J Clin Nutr 2000; 71: 1735s-8.
32. Morgan SL, Baggott JE. Medical foods: products for the management of chronic diseases. Nutrition Rev 2006; 64: 495-501.
33. Ford AC, Brandt LJ, Young C, et al. Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. Am J Gastroenterol 2009; 104: 1831-43.
34. Pimental M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. NEJM 2011; 364: 22-32.
35. Lembo AJ, Lacy BE, Zuckerman MJ, et al. Eluxadoline for irritable bowel syndrome with diarrhea. NEJM 2016; 374: 242-53.
36. Drossman DA, Chey WD, Johanson JF, et al. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome-results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther 2009; 29: 329-341.
37. Chey WD, Lembo AJ, Lavins BJ, et al. Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety. Am J Gastroenterol 2012; 107: 1702-12.